Cornerstone Planning’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$646K Sell
1,784
-5,270
-75% -$1.8M 0.15% 105
2026
Q1
$2.48M Buy
7,054
+492
+7% +$175K 0.56% 70
2025
Q4
$2.16M Buy
+6,562
New +$2.08M 0.5% 71
2024
Q4
$1.63M Buy
+6,260
New +$1.86M 0.62% 63

Other funds holding AMGN

Cornerstone Planning's AMGN Position: Q2 2026 in Review

Cornerstone Planning reduced its Amgen (AMGN) stake by 75% in Q2 2026, selling an estimated $1.8M and leaving 1,784 shares worth $646K. The position accounts for 0.15% of the portfolio, ranked #105.

Cornerstone Planning first reported a position in AMGN in Q4 2024 and has held it in 4 quarters since. The position peaked at $2.48M in Q1 2026. 3,133 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Cornerstone Planning held 1,784 shares of Amgen worth $646K as of Q2 2026.
  • Cornerstone Planning sold 5,270 Amgen shares in Q2 2026, an estimated $1.8M.
  • Amgen made up 0.15% of Cornerstone Planning's portfolio in Q2 2026, its #105 holding.
  • Cornerstone Planning first reported a position in Amgen in Q4 2024 and has held it in 4 quarters since.
  • Cornerstone Planning's Amgen position peaked at $2.48M in Q1 2026.
  • 3,133 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Cornerstone Planning's 13F filing for Q2 2026, filed 30 Jul 2026.